London’s Alchemab Therapeutics secures €29.3 million as British Business Bank makes its largest life sciences investment yet
Alchemab Therapeutics, a London-based clinical-stage BioTech startup, has extended its Series A financing with €29.3 million (£25 million/$34 million). This marks the British Business Bank’s largest investment in a life sciences company to date. This additional funding brings Alchemab’s total
<p>Alchemab Therapeutics, a London-based clinical-stage BioTech startup, has extended its Series A financing with €29.3 million (£25 million/$34 million). This marks the British Business Bank’s largest investment in a life sciences company to date. This additional funding brings Alchemab’s total</p>